1. Screening Libraries
  2. Clinical Compound Library

Clinical Compound Library

(1345 compounds) Cat. No.: HY-L026
Library Contents: XLSX PDF

New drug development is a time-consuming and high-cost process. Drug repurposing (also called drug repositioning, reprofiling or re‑tasking) offers various advantages over developing an entirely new drug for a given indication, such as lower risk and less investment. Clinical drugs have confirmed bioactivities, clear mechanisms and high safety that are suitable for drug repurposing.

MCE owns a unique collection of 1345 clinical compounds that refer to various research areas including anti-cancer, anti-infection, anti-inflammation, nervous disease. Those compounds are of detailed information on clinical development status, research area, targets, etc.

Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at


Top Publications Citing Use of Products

Customer Validation

MCE Screening Library Partners

  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

& Advantages

•   A unique collection of 1345 clinical compounds for high throughput screening (HTS) and high content screening (HCS).

•   Research areas include anticancer, anti-infection, anti inflammation, nervous disease, and more.

•   A useful tool for drug repurposing.

•   Currently in clinical stage, some are withdrawn or terminated.

•   Structurally diverse, medicinally active, and cell permeable.

•   Detailed compound information with structure, IC50, and brief introduction.

•   Validated NMR and HPLC to ensure high purity and quality.

•   All compounds are in stock and continuously updated.

Product Details
A collection of 1345 clinical compounds supplied as pre-dissolved Solutions or Solid
96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Blue ice

Contents of Clinical Compound Library

Plate layout: HY-L026-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty SKF-96365 (hydrochloride) MRT68921 (hydrochloride) TAK-438 (free base) Ufenamate CBR-5884 Calcitriol HLCL-61 (hydrochloride) Ro 41-1049 (hydrochloride) PD 117519 YYA-021 Empty
b Empty Faropenem daloxate Flavopiridol Flavopiridol (Hydrochloride) NPS-2143 SNS-032 Semagacestat Ko 143 KNK437 TA-01 AZD-5438 Empty
c Empty Tubercidin JNJ-17203212 Taranabant PAP-1 4-IBP Toll-like receptor modulator Methoxatin (disodium salt) SMER28 HC-067047 EAI045 Empty
d Empty RSL3 (1S,3R-) IQ-1S (free acid) EPZ015866 Madrasin SZL P1-41 Nutlin (3a) GSK583 SRI-011381 (hydrochloride) CL-82198 MS049 Empty
e Empty DMCM (hydrochloride) MRK-016 (RS)-MCPG E4CPG A 922500 Nigericin (sodium salt) BH3I-1 NKL 22 Brevianamide F NVP-BAW2881 Empty
f Empty F16 PF-04979064 Ro 67-7476 PHCCC FCCP LY2365109 (hydrochloride) Odanacatib Imazamox CCF642 HA15 Empty
g Empty WYE-125132 AEE788